An otherwise healthy 42-year-old woman is rushed to the hospital, fighting for her life against septic shock. She is on vasopressors, and the doctors are working against the clock to determine the best empiric, broad-spectrum antibiotic to fight what they believe is an out-of-control urinary tract infection. The preliminary diagnosis is confirmed. Her body is in a losing battle with extended-spectrum beta-lactamase (ESBL)-producing E. coli infection. The antibiotic treatment her attending team chooses next may be the difference between life and death for the patient. Laboratory legend: How your AST results support accurate antibiotic therapy in the battle against bacterial sepsis.
Uncover how Thermo Fisher Scientific empowers lab heroes like you in the global battle against bacterial sepsis. Learn how your clinical lab can make a difference using cutting-edge tools and resources.
Grab this whitepaper to explore:
- The critical role of AST in guiding antibiotic therapy
- Reviewing AST methods for E.coli and Klebsiella spp.
- Challenges in bacterial culture and AST
- The importance of laboratory accuracy and communication
- Future perspectives
